WADA Drops Lawsuit Against USADA Amid Chinese Swimmers Drug Test Controversy

The World Anti-Doping Agency (WADA) has dropped its lawsuit against the U.S. Anti-Doping Agency (USADA) concerning a dispute over 23 Chinese swimmers' failed drug tests before the 2021 Tokyo Olympics. WADA accepted Chinese officials' explanation of contamination, and USADA criticized WADA's transparency on the issue.

The World Anti-Doping Agency (WADA) announced the withdrawal of its lawsuit against the U.S. Anti-Doping Agency (USADA) concerning the controversial case of 23 Chinese swimmers who failed drug tests before the 2021 Tokyo Olympics.

The swimmers, who tested positive, were not sanctioned following an explanation from Chinese authorities, who claimed that a banned substance was inadvertently introduced through contaminated spice containers at a hotel. USADA criticized WADA for what it called inadequate transparency and lack of provisional suspension.

WADA had initiated the lawsuit to protect its integrity but ended it after a Swiss investigation found no bias in their conduct. WADA expressed a desire to refocus on improving the anti-doping system globally. USADA's CEO, Travis Tygart, has yet to comment publicly on WADA's decision.